Dashboard
1
Poor Management Efficiency with a low ROCE of 0%
- The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward
2
Poor long term growth as Net Sales has grown by an annual rate of -6.15% and Operating profit at 3.56% over the last 5 years
3
Risky -
4
Market Beating performance in long term as well as near term
Stock DNA
Pharmaceuticals & Biotechnology
CNY 3,005 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.25
-33.90%
1.74
Revenue and Profits:
Net Sales:
159 Million
(Quarterly Results - Jun 2025)
Net Profit:
-5 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
64.44%
0%
64.44%
6 Months
77.25%
0%
77.25%
1 Year
104.14%
0%
104.14%
2 Years
69.14%
0%
69.14%
3 Years
57.45%
0%
57.45%
4 Years
48.0%
0%
48.0%
5 Years
83.85%
0%
83.85%
Zhong Zhu Healthcare Holding Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-6.15%
EBIT Growth (5y)
3.56%
EBIT to Interest (avg)
-52.61
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.23
Tax Ratio
1.49%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0.07%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.74
EV to EBIT
-5.90
EV to EBITDA
-6.97
EV to Capital Employed
1.99
EV to Sales
4.59
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-33.72%
ROE (Latest)
-33.90%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
159.20
139.80
13.88%
Operating Profit (PBDIT) excl Other Income
10.50
-5.90
277.97%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-5.40
-17.20
68.60%
Operating Profit Margin (Excl OI)
-35.00%
-156.90%
12.19%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 13.88% vs 4.64% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is 68.60% vs 96.78% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
506.40
580.10
-12.70%
Operating Profit (PBDIT) excl Other Income
-207.70
-45.10
-360.53%
Interest
1.10
7.70
-85.71%
Exceptional Items
-175.30
-242.50
27.71%
Consolidate Net Profit
-625.20
-338.40
-84.75%
Operating Profit Margin (Excl OI)
-549.30%
-233.10%
-31.62%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -12.70% vs 46.38% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -84.75% vs 57.26% in Dec 2023
About Zhong Zhu Healthcare Holding Co., Ltd. 
Zhong Zhu Healthcare Holding Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






